Pär Ewing

455 total citations
17 papers, 367 citations indexed

About

Pär Ewing is a scholar working on Pulmonary and Respiratory Medicine, Physiology and Pharmaceutical Science. According to data from OpenAlex, Pär Ewing has authored 17 papers receiving a total of 367 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Pulmonary and Respiratory Medicine, 7 papers in Physiology and 3 papers in Pharmaceutical Science. Recurrent topics in Pär Ewing's work include Inhalation and Respiratory Drug Delivery (12 papers), Asthma and respiratory diseases (7 papers) and Drug Solubulity and Delivery Systems (3 papers). Pär Ewing is often cited by papers focused on Inhalation and Respiratory Drug Delivery (12 papers), Asthma and respiratory diseases (7 papers) and Drug Solubulity and Delivery Systems (3 papers). Pär Ewing collaborates with scholars based in Sweden, United Kingdom and United States. Pär Ewing's co-authors include Per Gerde, Markus Fridén, Åke Ryrfeldt, Anders Lundqvist, Neil D. Evans, Göran Lidén, Lena Låstbom, Fernando Acevedo, Maria Malmlöf and Katarina Ekelund and has published in prestigious journals such as ACS Nano, Journal of Controlled Release and Journal of Pharmacology and Experimental Therapeutics.

In The Last Decade

Pär Ewing

17 papers receiving 352 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Pär Ewing Sweden 11 259 108 106 49 38 17 367
Jens Markus Borghardt Germany 8 270 1.0× 132 1.2× 89 0.8× 65 1.3× 24 0.6× 20 425
Priya Muralidharan United States 9 335 1.3× 71 0.7× 153 1.4× 61 1.2× 54 1.4× 16 440
David Christopher United States 10 203 0.8× 57 0.5× 112 1.1× 30 0.6× 61 1.6× 30 398
Poonam Sheth United States 11 339 1.3× 93 0.9× 253 2.4× 73 1.5× 75 2.0× 18 585
Paul J. Atkins United States 7 209 0.8× 89 0.8× 60 0.6× 42 0.9× 37 1.0× 18 354
Ann Tronde Sweden 11 327 1.3× 138 1.3× 172 1.6× 39 0.8× 29 0.8× 11 457
Annalisa Mercuri Austria 10 113 0.4× 49 0.5× 226 2.1× 41 0.8× 113 3.0× 16 522
Paul Colthorpe Switzerland 8 344 1.3× 152 1.4× 95 0.9× 101 2.1× 64 1.7× 10 493
Bhawana Saluja United States 11 188 0.7× 61 0.6× 81 0.8× 41 0.8× 35 0.9× 18 313
Jack Dummer New Zealand 13 215 0.8× 136 1.3× 32 0.3× 235 4.8× 20 0.5× 33 543

Countries citing papers authored by Pär Ewing

Since Specialization
Citations

This map shows the geographic impact of Pär Ewing's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Pär Ewing with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Pär Ewing more than expected).

Fields of papers citing papers by Pär Ewing

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Pär Ewing. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Pär Ewing. The network helps show where Pär Ewing may publish in the future.

Co-authorship network of co-authors of Pär Ewing

This figure shows the co-authorship network connecting the top 25 collaborators of Pär Ewing. A scholar is included among the top collaborators of Pär Ewing based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Pär Ewing. Pär Ewing is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
Ewing, Pär, et al.. (2023). Biodistribution of Intravenously Administered Tozorakimab in Porcine Tissues. A5753–A5753. 1 indexed citations
2.
Bates, Stephanie M., et al.. (2021). Controlled Pulmonary Delivery of Carrier-Free Budesonide Dry Powder by Atomic Layer Deposition. ACS Nano. 15(4). 6684–6698. 41 indexed citations
3.
Ewing, Pär, et al.. (2020). Airway Epithelial Lining Fluid and Plasma Pharmacokinetics of Inhaled Fluticasone Propionate and Salmeterol Xinafoate in Mechanically Ventilated Pigs. Journal of Aerosol Medicine and Pulmonary Drug Delivery. 34(4). 231–241. 2 indexed citations
4.
5.
Cselényi, Zsolt, Aurelija Jučaitė, Per Stenkrona, et al.. (2020). Quantification and reliability of [11C]VC - 002 binding to muscarinic acetylcholine receptors in the human lung — a test-retest PET study in control subjects. EJNMMI Research. 10(1). 4 indexed citations
6.
Zaidi, Syed Saoud, et al.. (2019). Fetal Concentrations of Budesonide and Fluticasone Propionate: a Study in Mice. The AAPS Journal. 21(4). 53–53. 2 indexed citations
7.
Schou, Magnus, Pär Ewing, Zsolt Cselényi, et al.. (2019). Pulmonary PET imaging confirms preferential lung target occupancy of an inhaled bronchodilator. EJNMMI Research. 9(1). 9–9. 9 indexed citations
8.
Gerde, Per, et al.. (2017). Dissolv It : An In Vitro Method for Simulating the Dissolution and Absorption of Inhaled Dry Powder Drugs in the Lungs. Assay and Drug Development Technologies. 15(2). 77–88. 39 indexed citations
9.
Evans, Neil D., et al.. (2016). Systems Pharmacology Approach for Prediction of Pulmonary and Systemic Pharmacokinetics and Receptor Occupancy of Inhaled Drugs. CPT Pharmacometrics & Systems Pharmacology. 5(4). 201–210. 56 indexed citations
10.
Ewing, Pär, et al.. (2015). A Novel In Vivo Receptor Occupancy Methodology for the Glucocorticoid Receptor: Toward An Improved Understanding of Lung Pharmacokinetic/Pharmacodynamic Relationships. Journal of Pharmacology and Experimental Therapeutics. 353(2). 279–287. 14 indexed citations
11.
Lundqvist, Anders, et al.. (2015). Development of a Novel Lung Slice Methodology for Profiling of Inhaled Compounds. Journal of Pharmaceutical Sciences. 105(2). 838–845. 37 indexed citations
12.
Thielemans, Wim, David Pritchard, Stuart W. Paine, et al.. (2013). Polyethylene glycol-drug ester conjugates for prolonged retention of small inhaled drugs in the lung. Journal of Controlled Release. 171(2). 234–240. 32 indexed citations
13.
Ewing, Pär, et al.. (2012). Dry Powder Inhalation Exposures of the Endotracheally Intubated Rat Lung, Ex Vivo and In Vivo : The Pulmonary Pharmacokinetics of Fluticasone Furoate. Journal of Aerosol Medicine and Pulmonary Drug Delivery. 26(4). 181–189. 34 indexed citations
14.
Ewing, Pär, et al.. (2009). Vasoconstriction after inhalation of budesonide: A study in the isolated and perfused rat lung. Pulmonary Pharmacology & Therapeutics. 23(1). 9–14. 10 indexed citations
15.
Lundborg, Margot, Per Gerde, Pär Ewing, et al.. (2007). Aggregates of ultrafine particles modulate lipid peroxidation and bacterial killing by alveolar macrophages. Environmental Research. 104(2). 250–257. 24 indexed citations
16.
17.
Clarke, Cyril R., et al.. (1992). Pharmacokinetics of intravenously and orally administered pyrimethamine in horses.. PubMed. 53(12). 2292–5. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Jens Markus Borghardt Breakdown of academic impact, for papers by Priya Muralidharan Breakdown of academic impact, for papers by David Christopher Breakdown of academic impact, for papers by Poonam Sheth Breakdown of academic impact, for papers by Paul J. Atkins Breakdown of academic impact, for papers by Ann Tronde Breakdown of academic impact, for papers by Annalisa Mercuri Breakdown of academic impact, for papers by Paul Colthorpe Breakdown of academic impact, for papers by Bhawana Saluja Breakdown of academic impact, for papers by Jack Dummer
Rankless by CCL
2026